neonat screen strategi cystic fibrosi immunoreact trypsinogen direct gene analysi object effect neonat screen strategi cystic fibrosi estim immunoreact trypsinogen direct gene analysi dri blood spot sampl age day design prospect studi strategi first tier immunoreact trypsinogen concentr dri blood spot sampl neonat day second tier direct gene analysi cystic fibrosi mutat blood spot sampl immunoreact trypsinogen valu direct gene analysi blood spot sampl infant suspect confirm meconium ileu immunoreact trypsinogen valu set south australian neonat screen programm depart chemic patholog adelaid children hospit subject neonat south australia decemb june select criteria intervent infant cystic fibrosi mutat direct gene analysi clinic manag cystic fibrosi mutat sweat test famili genet counsel main outcom measur direct exclus cystic fibrosi sweat test neonat high risk cystic fibrosi minimum risk subsequ clinic histori suspicion diseas result infant cystic fibrosi basi low immunoreact trypsinogen valu immunoreact trypsinogen valu meconium ileu cystic fibrosi cystic fibrosi sweat test direct gene analysi presenc cystic fibrosi mutat case affect infant date conclus strategi measur immunoreact trypsinogen direct gene analysi specif neonat screen cystic fibrosi famili case cystic fibrosi 